牙周炎和与代谢功能障碍相关的脂肪性肝病:强调肝病学家和牙医之间的临床相互作用
Nasser Mousa1,2, Alaa Elmetwalli3, Ahmed Abdel-Razik4
1Tropical Medicine Department, Mansoura University, Mansoura, Egypt. mousa_medic@yahoo.com.
Odontology
|September 15, 2025
概括
牙周炎是一种口腔疾病,可能会恶化代谢功能障碍相关的性肝病 (MASLD) 由于共享的风险因素,如炎症. 改善牙健康可能有利于肝脏健康.
科学领域:
- 肝病学和牙周病学
- 研究口腔健康和肝脏疾病之间的相互作用.
- 在代谢功能障碍中探索口腔-肠-肝脏轴.
背景情况:
- 代谢功能障碍相关的性肝病 (MASLD) 是全球最常见的肝病.
- 牙周炎是一种流行的炎症性口腔疾病.
- 新出现的证据表明牙周炎和MASLD进展之间存在联系.
研究的目的:
- 审查和阐明牙周炎和MASLD之间的联系.
- 提高医疗保健提供者对口腔健康与肝病关系的认识.
- 为了指导患者在肝病的背景下管理口腔健康.
主要方法:
- 在PubMed,Scopus和Web of Science中进行全面的文献搜索.
- 包括不同类型的研究:初级研究,评论,指南和专家意见.
- 专注于最近的出版物和研究,探讨致病性联系和口腔-肠-肝脏轴.
主要成果:
- 牙周炎和MASLD具有共同的风险因素,包括肥胖,胰岛素抵抗和炎症.
- 牙周炎的慢性炎症可能会通过增加胰岛素抵抗和全身炎症而加剧MASLD.
- 口腔微生物组失调可以导致细菌转移,全身炎症,并可能恶化肝损伤.
结论:
- 改善牙周健康可能会对MASLD的进展和患者的结果产生积极影响.
- 合作性牙科和医疗护理模型对于管理患有这两种疾病的患者至关重要.
- 了解口腔肠肝轴对于解决牙周炎和MASLD之间的联系至关重要.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Chronic Pancreatitis II: Collaborative Care
315
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
315
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
215
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
215
Overview of Lipid Metabolism
4.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.9K
Overview of Carbohydrate Metabolism
3.3K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.3K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169


